Article
Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors.
BMC cancer - 19 Mar 2014
Pfeil Alena M, Vulsteke Christof, Paridaens Robert, Dieudonné Anne-Sophie, Pettengell Ruth, Hatse Sigrid, Neven Patrick, Lambrechts Diether, Szucs Thomas D, Schwenkglenks Matthias, Wildiers Hans
Abstract excerpt
BACKGROUND: Febrile neutropenia (FN) is common in breast cancer patients undergoing chemotherapy. Risk factors for FN have been reported, but risk models that include genetic variability have yet to be described. This study aimed to evaluate the predictive value of patient-related, chemotherapy-related, and genetic risk factors. METHODS: Data from consecutive breast cancer patients receiving chemotherapy with 4-6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.